“…Between 1998 and 2009, the British Thoracic Society 4 , the United Kingdom's National Health Service Cancer Plan [5][6][7] , the RAND Corporation 8,9 , the American College of Chest Physicians 10 , and Cancer Care Ontario 2 all published recommendations for target time intervals in the trajectory of diagnosis and treatment for lung cancer (Table i). However, although timely care can contribute substantially to quality of life and emotional well-being for patients, the literature concerning the effect of timeliness on other patient outcomes does not show a clear association between earlier initiation of anticancer treatment and improved survival [11][12][13][14] .…”